Arman
Rahmim
Professor, Depts of Radiology and Physics & Astronomy
Distinguished Scientist, BC Cancer Research Institute
Canada Research Chair in Theranostics and AI
Research Theme:
Imaging & Computational Biology,Research Interests:
Improved cancer diagnosis, prognosis & therapy by quantifying how radiopharmaceuticals target cancer cells; machine learning; radiomics; theranostics
Biography:
Dr. Rahmim has published a book and >360 journal articles, and delivered >220 invited lectures worldwide. He also hosts the Molecular Imaging & Therapy YouTube channel to help disseminate learning for a wide worldwide audience. He is Scientific Lead of the BC Cancer Medical Imaging Core (CanMIC) Lab, aiming to translate state-of-the-art imaging solutions to clinical trials and research. Additionally, he is Co-Founder and Chief Scientific Officer of Ascinta Technologies, working to develop easy-to-use, adaptable, and AI-enabled solutions for theranostics and radiopharmaceutical therapies.
Dr. Rahmim was awarded in 2022 the Presidential Distinguished Service Award by the Society of Nuclear Medicine & Molecular Imaging (SNMMI) for significant contributions to the field of nuclear medicine & molecular imaging, and in 2025 the SNMMI Edward Hoffman Memorial Award for outstanding contributions to computational nuclear medicine research, best-practice, training and education. He has served as Vice President (2017-18) and President (2018-19) of the SNMMI Physics, Instrumentation and Data Sciences Council (PIDSC), as well as Founding Chair of the AI Task Force (2020-2024) and the Computational Nuclear Oncology (CNO) Working Group (2022-).